Folate receptor alpha is widely expressed and a potential therapeutic target in uterine and ovarian carcinosarcoma-Reference-Cited by-同舟云学术

Folate receptor alpha is widely expressed and a potential therapeutic target in uterine and ovarian carcinosarcoma

Published:2023-09 Issue: Volume:176 Page:115-121
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Saito Ayumi,Nishikawa Tadaaki,Yoshida Hiroshi,Mizoguchi Chiharu,Kitadai Rui,Yamamoto Kasumi,Yazaki Shu,Kojima Yuki,Ishikawa Mitsuya,Kato Tomoyasu,Yonemori Kan

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference41 articles.

1. Trends of uterine carcinosarcoma in the United States;Matsuo;J. Gynecol. Oncol.,2018

2. Carcinosarcoma of the ovary: a review of the literature;del Carmen;Gynecol. Oncol.,2012

3. Impact of histology and surgical approach on survival among women with early-stage, high-grade uterine cancer: an NRG oncology/gynecologic oncology group ancillary analysis;Fader;Gynecol. Oncol.,2016

4. Carcinosarcoma of the ovary compared to papillary serous ovarian carcinoma: a SEER analysis;Rauh-Hain;Gynecol. Oncol.,2013

5. FOLR1 [Internet],2022

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody-Drug Conjugates: The New Treatment Approaches for Ovarian Cancer;Cancers;2024-07-15

2. 177Lu-FA-DOTA-PEG-PLGA Nanoparticles Show Antitumor Efficiency in Targeting Ovarian Cancer;Clinical and Experimental Obstetrics & Gynecology;2024-05-14

3. Folate Receptor Alpha—A Novel Approach to Cancer Therapy;International Journal of Molecular Sciences;2024-01-15

4. Mirvetuximab soravtansine-gynx: first antibody/antigen-drug conjugate (ADC) in advanced or recurrent ovarian cancer;International Journal of Gynecologic Cancer;2023-12-14